Alnylam Pharmaceuticals Inc.
ALNY | NASDAQ
$244.32
+$4.76 (+1.99%)
At close: Sep 21, 2026, 4:00 PM ET
$244.35
+$0.03 (+0.01%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 166.38 | -107.94 | -54.38 | -25.55 | -23.55 | -17.42 |
PEG Ratio | -0.79 | 2.84 | 0.87 | -0.88 | 6.76 | 2.17 |
PS Ratio | 14.03 | 13.36 | 13.08 | 27.88 | 23.79 | 30.32 |
PB Ratio | 66.01 | 447.73 | -108.36 | -182.78 | 34.15 | 14.71 |
P/FCF Ratio | 111.94 | -705.29 | 569.99 | -47.15 | -27.97 | -21.81 |
P/OCF Ratio | 99.40 | -3.61K | 229.54 | -53.43 | -31.30 | -24.30 |
OCF/S Ratio | 14.11 | -0.37 | 5.70 | -52.18 | -76 | -124.78 |
Debt / Equity Ratio | 1.62 | 40.89 | -5.92 | -8.34 | 1.70 | 0.51 |
Quick Ratio | 2.71 | 2.71 | 2.99 | 3.34 | 3.91 | 4.34 |
Current Ratio | 2.76 | 2.78 | 3.08 | 3.51 | 4.04 | 4.47 |
Asset Turnover | 0.75 | 0.53 | 0.48 | 0.29 | 0.23 | 0.14 |
Interest Coverage | 1.99 | -1.25 | -2.33 | -5.03 | -4.95 | -9.80 |
Return on Equity | 39.76% | -414.62% | 199.53% | 714.91% | -144.99% | -84.46% |
Return on Assets | 6.32% | -6.56% | -11.49% | -31.90% | -23.41% | -25.19% |
Return on Invested Capital | 13.74% | -4.06% | -9.72% | -27.84% | -23.72% | -28.98% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 81.77% | 85.62% | 83.02% | 83.73% | 83.40% | 84.16% |
Net Profit Margin | 8.45% | -12.37% | -24.08% | -109.04% | -101.01% | -174.15% |
Pretax Profit Margin | 8.70% | -16.79% | -23.71% | -108.63% | -100.93% | -173.60% |
Operating Profit Margin | 13.51% | -7.87% | -15.43% | -75.68% | -83.94% | -168.09% |
FCF Margin | 12.53% | -1.89% | 2.29% | -59.12% | -85.05% | -139.05% |
EBITDA Margin | 17% | -7.96% | -14.12% | -89.31% | -78.36% | -149.40% |
Add to Watchlist
Select watchlists to add or remove ALNY